**Headline:** AstraZeneca Partners with Chinese Company for Global Rights to Monthly Weight Loss Injections
AstraZeneca has reached an agreement with Chinese pharmaceutical firm CSPC to obtain exclusive global rights, excluding China, to CSPC’s once-a-month weight management injections. The collaboration allows AstraZeneca to expand its portfolio in the weight loss treatment market. Under the deal, AstraZeneca will have the rights to develop, manufacture, and commercialize …